Background There has been renewed interest in cold-stored platelets (CSPs) for the management of bleeding patients. CSPs might offer advantages over conventional room temperature stored platelet uni.....

This Special Communication discusses the updated Association for the Advancement of Blood and Biotherapies and the International Collaboration for Transfusion Medicine Guidelines international clinica...

In the United States and other high-income countries, blood donation primarily relies on anonymous, voluntary donors. However, directed blood donation—where people donate for a specific recipient—has ...

Maria De Los Angeles Muñiz, MD, discusses translating critical information to improve global access and her passion to educate the next generation of Puerto Rican leaders in the field.

TRANSFUSION’s Monthly Podcast will examine questions big and small about transfusion medicine and its role in supporting patients and society. The TRANSFUSION podcast will highlight new individual sc

There is no better time to set yourself the goal of becoming a CABP in 2025. First established in 2021 by AABB (Association for the Advancement of Blood & Biotherapies), the Certified Advanced Biother...

One of the most valuable substances in the world has never been replicated. Are we close?

Researchers found no evidence that CAR T cell therapy caused any type of secondary cancer in the modified T cells, according to new analysis from the Perelman School of Medicine and the Abramson Cance...

Background Storage of packed red blood cells (RBCs) for transfusion leads to biochemical and morphological changes, increasing hemolysis risk. Urate levels in blood bags at donation contribute to th...

A virtual reality blood transfusion training programme that could help save lives has been created by a Manchester Metropolitan doctoral student. Clinical

Background Intravenous immunoglobulin (IVIG) shortage represents an emerging issue in transfusion medicine. Limited data are available to determine effective strategies for optimal use. The objectiv...

Click on the article title to read more.

Background Group AB plasma does not contain anti-A or anti-B antibodies and is therefore considered universal but is in limited supply (4% of the population). There is currently no licensed universa...

In the years after the tainted blood crisis, she became a leader in her field, using research to help safeguard and improve the national blood and plasma supply system

Background The COVID-19 pandemic exerted an unprecedented impact on the blood supply from 2020 through 2022. As a result, throughout 2021 there were months our hospital had less than one-day supply ...